JAMA Forum | FDA’s Policy Changes for COVID-19 At-Home Diagnostics—Implications for Addressing Other Infectious Diseases and Future Pandemics

In an article from December 23rd, 2021, Scott Gottlieb, MD from the American Enterprise Institute in Washington, DC discussed how the most enduring technological innovation of the pandemic so far may be the advent of accurate diagnostic tests that can be used at home to provide a rapid answer about a person’s clinical status. He examines the FDA’s regulatory framework, evolved to advance these tests, and the technology and commercial pathway that can provide them directly to consumers. Gottlieb discusses how the cultural changes that rapid diagnostic tests have ushered in will affect our approach to care and have lasting consequences beyond COVID-19 in addressing other infectious diseases.

You can read the full article here: https://jamanetwork.com/journals/jama-health-forum/fullarticle/2787641

Leave a Reply

Your email address will not be published. Required fields are marked *

thirteen + 5 =